Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.
Bitcoin, Ethereum, Dogecoin Fall Amid Inflation Worries: Analyst Says If Apex Coin Was Superman Then Fed Tightening Is Its Kryptonite
Major cryptocurrencies are back slightly in the red on Wednesday evening following renewed concerns regarding inflation.
